International Agencies

The overall goal of the training course is to further develop the skills required to plan and implement collaborative TB/HIV activities based on the strategies for controlling TB and HIV/AIDS recommended by WHO.
Includes a manual for participants, a guide for facilitators, and a guide for the course director.

This document guides NTPs on how to engage all relevant health care providers in TB control and thereby promote the use of evidence-based, International Standards for TB Care. The experience and evidence on scaling up and sustaining PPM is now clearly emerging. The authors hope that this document will help countries to scale up PPM DOTS more rapidly and contribute significantly to achieving the TB-related Millennium Development Goal.

This monograph is a case study of integrated monitoring and evaluation of treatment for HIV/TB in Malawi.

The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.

This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to further scale up its activities.

Based on The Union's 93-years of working in the field, the new guide tackles the challenges of fulfilling each patient's potential for cure from both the clinician's and the programme manager's perspective.

This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.

The primary purposes of this framework are to: 1) promote, enhance, and intensify TB research and innovation at the country level, and 2) promote, enhance, and catalyze TB research at the global level through advocacy, innovation, discussion of global priorities, and the development of networks for research and capacity building.

The TB Stigma Assessment Tool was created to help countries recognize why, when and where stigma happens, and understand the impact stigma has. By using the tool, countries and their national TB programs can be better equipped to develop targeted health and human rights actions to address stigma.

This fact sheet explains the purpose of the Global Drug Facility (GDF) to expand access to, and availability of, high-quality TB drugs to facilitate DOTS expansion, and to enable governments and nongovernmental organizations (NGOs) to implement effective TB control programs based upon the DOTS stragegy.

This report discusses the relationship between TB and sustainable development, and advocates for increased dialogue and action among TB partners.